Salix Pharmaceuticals Ltd.

Teva may grapple with questions about how its Austedo (deutetrabenzene) is worth the price premium over generic tetrabenzene while negotiating a “maximum fair price” with the US Centers for Medicare

The Institute for Clinical and Economic Review’s report on unsupported price increases found that combined, the 10 drugs that had net price increases that contributed the most to US health care system

AdipoPharma SAS is developing what it hopes will be the first drug candidate to target adipose tissue in an attempt to address the root cause of type 2 diabetes, namely insulin resistance. The compan

[ Editor's Note: A version of this article originally appeared in Scrip . For more insight on the the B+L spin-off from the perspective of the over-the-counter industry, see Informa's HBW Insig